{"Title": "Spinal cord atrophy rates: Ready for prime time in multiple sclerosis clinical trials?", "Year": 2018, "Source": "Neurology", "Volume": "91", "Issue": 4, "Art.No": null, "PageStart": 157, "PageEnd": 158, "CitedBy": 5, "DOI": "10.1212/WNL.0000000000005873", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064846040&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Atrophy", "Disease Progression", "Humans", "Multiple Sclerosis", "Multiple Sclerosis, Chronic Progressive", "Spinal Cord"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85064846040", "SubjectAreas": [["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"57193550334": {"Name": "Prados F.", "AuthorID": "57193550334", "AffiliationID": "60019953, 60022148, 60001997", "AffiliationName": null}, "7102989379": {"Name": "Barkhof F.", "AuthorID": "7102989379", "AffiliationID": "60019953, 60022148, 60001997", "AffiliationName": null}}}